- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
活血消癓方和化止痛方对子宫腺肌病痛经免疫调节作用的影响研究
The Research on the Immunomodulatory Effects of
HuoXueXiaoZheng Fang and HuaYu ZhiTong Fang to Adenomyosis
with Symptoms of Dysmenorrhea
Speciality: Gynecology of TCM,The study of menstruation sickness and sterility
Tutor: Professor Ye Qing
Author: Zhang Chunyan
Abstract
Objective: This study was performed to observe the clinical effectiveness of the
treatments on patients suffering from dysmenorrhea with ademyosis by stages using
HuoXueXiaoZhengFang (HXXZF) and HuaYuZhiTongFang (HYZTF). Their effects on
blood-related immune parameters are observed, which is to explore their
immunomodulatory effects in patients suffering from dysmenorrhea with ademyosis.
Methods: Fifty adenomyosis patients suffering from dysmenorrhea (twenty-six for the
treatment group and twenty-four for the control group) were enrolled. The treatment group
took HXXZF and HYZTF at stage, while the control group took DanHuangQuYu capsule
and SanJieZhenTong capsule at stage. The curative effects and impacts on the size
of uterine volume, CA125, EMAb, whole blood T cell subsets and C3, C4 of serum
complement were observed. Results: After treatment symptoms of dysmenorrhea of the
two groups have been improved and there was a significant difference between the two
groups in curative effects (
P0.050.05 or P0.01 ). Compared with pre-treatment there were
significant reductions in uterine volume (P0.01) in the treatment group, while there were
no significant differences in the control group (P0.05 ). There were significant differences
between the two groups (P0.05 ). The positive rate of EMAb decreased in both groups after
treatment (P0.05 ), but no s
文档评论(0)